KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Operating Leases (2018 - 2025)

Biogen (BIIB) has 8 years of Operating Leases data on record, last reported at $370.8 million in Q4 2025.

  • For Q4 2025, Operating Leases rose 10.85% year-over-year to $370.8 million; the TTM value through Dec 2025 reached $370.8 million, up 10.85%, while the annual FY2025 figure was $370.8 million, 10.85% up from the prior year.
  • Operating Leases reached $370.8 million in Q4 2025 per BIIB's latest filing, up from $305.0 million in the prior quarter.
  • Across five years, Operating Leases topped out at $490.3 million in Q4 2023 and bottomed at $274.2 million in Q2 2022.
  • Average Operating Leases over 5 years is $351.1 million, with a median of $341.3 million recorded in 2021.
  • Peak YoY movement for Operating Leases: crashed 31.9% in 2021, then soared 47.24% in 2023.
  • A 5-year view of Operating Leases shows it stood at $330.4 million in 2021, then increased by 0.79% to $333.0 million in 2022, then soared by 47.24% to $490.3 million in 2023, then crashed by 31.78% to $334.5 million in 2024, then increased by 10.85% to $370.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $370.8 million in Q4 2025, $305.0 million in Q3 2025, and $310.9 million in Q2 2025.